Oral Mucositis: Time for More Studies
- 1 January 2002
- journal article
- review article
- Published by Taylor & Francis in Hematology
- Vol. 7 (5) , 281-289
- https://doi.org/10.1080/1024533021000037216
Abstract
Oral Mucositis (OM) is a frequent cause of severe morbidity in patients receiving chemotherapy and/or radiotherapy. The pathophysiology of OM involves direct cytotoxic effects, local inflammatory responses, and alterations in oral microflora. There are currently no approved agents for the prevention or treatment of OM. In this review we briefly describe current knowledge of the pathophysiology, clinical presentation, and management of OM. We then discuss investigational agents being studied in OM with a particular focus on local antimicrobial agents, hemopoietic growth factors, and cytokines. Measures to reduce the incidence of OM and/or alleviate its clinical sequelae should be incorporated into all chemotherapy or radiotherapy studies.Keywords
This publication has 55 references indexed in Scilit:
- Iseganan HCl: a novel antimicrobial agentExpert Opinion on Investigational Drugs, 2002
- Oral pseudomembranous candidiasis, herpes simplex virus‐1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) mouthwashJournal of Oral Pathology & Medicine, 2001
- Oral colonization of aerobic and facultatively anaerobic gram‐negative rods and cocci in irradiated, dentate, xerostomic individualsOral Microbiology and Immunology, 2001
- Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescueBritish Journal of Haematology, 2000
- Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamstersOral Oncology, 2000
- Clinical and histopathological evaluation of sucralfate in prevention of oral mucositis induced by radiation therapy in patients with head and neck malignanciesOral Oncology, 1999
- Membrane Thinning Effect of the β-Sheet Antimicrobial ProtegrinBiochemistry, 1999
- The effect of granulocyte colony-stimulating factor on oral mucositis in head and neck cancer patients treated with hyperfractionated radiotherapyOral Oncology, 1999
- Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trialBone Marrow Transplantation, 1998
- Povidone-Iodine to Prevent Mucositis in Patients during Antineoplastic RadiochemotherapyDermatology, 1997